Word

AUTOLUS

Status

Registered

Status Code

700

Status Date

Tuesday, July 4, 2023

Serial Number

79338455

Registration Number

7095476

Registration Date

Tuesday, July 4, 2023

Mark Type

4000

Filing Date

Wednesday, March 2, 2022

Published for Opposition

Tuesday, April 18, 2023

Trademark Owner History

Autolus Limited - Original Registrant

Classifications

5 Medical and veterinary preparations for therapeutic purposes, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for cell therapy, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for gene therapy, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for the treatment of cancer; cells for medial or clinical use, namely cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; antibodies for medical purposes for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors, namely, culture media for cultivating and augmentation of human and animal cells; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes

44 Medical services; veterinary services; medical and veterinary services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes namely, medical services relating to the removal, treatment and processing of human and animal cells; medical and veterinary services in the nature of reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies

42 Scientific and technological services and research and design relating thereto, namely medical research, scientific research, analysis and testing in the field of human and animal cell and gene therapies, pharmaceutical product development, research and development of new products; industrial analysis and research services in the field of cell and gene therapies ; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services

Trademark Events

Oct 31, 2023

Final Decision Transaction Processed By Ib

Oct 6, 2023

Final Disposition Notice Sent To Ib

Oct 5, 2023

Final Disposition Processed

Oct 4, 2023

Final Disposition Notice Created, To Be Sent To Ib

Jul 4, 2023

Notice Of Registration Confirmation Emailed

Jul 4, 2023

Registered-Principal Register

May 9, 2023

Notification Processed By Ib

Apr 18, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 18, 2023

Published For Opposition

Apr 5, 2023

Notification Of Possible Opposition Sent To Ib

Apr 5, 2023

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 29, 2023

Notification Of Notice Of Publication E-Mailed

Mar 15, 2023

Approved For Pub - Principal Register

Mar 13, 2023

Teas/Email Correspondence Entered

Mar 11, 2023

Correspondence Received In Law Office

Mar 11, 2023

Teas Response To Office Action Received

Mar 5, 2023

Refusal Processed By Ib

Feb 9, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Feb 8, 2023

Refusal Processed By Mpu

Dec 15, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Dec 14, 2022

Non-Final Action Written

Dec 14, 2022

Assigned To Examiner

Apr 19, 2022

Application Filing Receipt Mailed

Apr 15, 2022

New Application Office Supplied Data Entered

Apr 14, 2022

Sn Assigned For Sect 66a Subseq Desig From Ib